Drug Trial Radar · NCT00277212
A Phase IV Study of the Safety and Efficacy of Aripiprazole in Combination With Lamotrigine in the Long-Term Maintenance Treatment of Patients With Bipolar I Disorder With A Recent Manic or Mixed Episode
Last checked: Nov 19, 2026Latest source record: May 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,169
Actual
Start
Dec 1, 2005
Primary completion
Jul 1, 2009
Study completion Jul 1, 2009
Sponsor
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.Otsuka
- Sponsor type
- Industry
- Collaborators
- Otsuka America Pharmaceutical
- First posted
- Jan 16, 2006
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Efficacy of Aripiprazole in Combination with Lamotrigine in the Long-Term Maintenance Treatment of Bipolar I Disorder in Outpatients with Recent Manic or Mixed Episode
Conditions
- Bipolar Disorder
Interventions
Lamotrigine + AripiprazoleDrug
Tablets, Oral, once daily, Phase 1 (all subjects) - up to 24 weeks; Phase 2 - up to 52 weeks Lamotrigine 100-200 mg/day Aripiprazole 10-30 mg/day
Lamotrigine + PlaceboDrug
Tablets, Oral, once daily, Phase 2 - up to 52 weeks Lamotrigine 100-200 mg/day placebo 0 mg/day
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Participants Not Experiencing Relapse Through Week 52 in the Double-Blind Relapse Assessment Phase (Phase 2)Time frame: Weeks 0, 2, 4, 6, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52
Locations
66 sites in 2 countries. Site status is shown where the registry gives one.
University Of Alabama At Birmingham
Birmingham, Alabama
Southwest Biomedical Research Foundation
Tucson, Arizona
Pravin Kansagra, M.D.
Anaheim, California
College Hospital Costa Mesa
Costa Mesa, California
Pacific Institute For Medical Research, Inc.
Los Angeles, California
Excell Research
Oceanside, California
Southern Ca Clinical Research, Inc.
Pasadena, California
Stanford University
Stanford, California
Los Angeles Biomedical Research Institute
Torrance, California
Pacific Clinical Research Medical Group
Upland, California
Health Sciences America, Llc
Boca Raton, Florida
Cns Clinical Research Group
Coral Springs, Florida
Act Clinical Research Institute, Llc
Daytona Beach, Florida
Neuropsychiatric Research Center Of Southwest Florida
Fort Myers, Florida
Aurora-Cuervo Clinical Trials
Miami, Florida
Gulf Coast Medical Research
Port Charlotte, Florida
Janus Center For Psychiatric Research
West Palm Beach, Florida
Comprehensive Neuroscience, Inc
Atlanta, Georgia
Valle Vista Health System
Greenwood, Indiana
Clinco
Terre Haute, Indiana
Clinical Trials Technology, Inc
Prairie Village, Kansas
Clinical Research Institute
Wichita, Kansas
University Of Kentucky, Dept. Of Psychiatry
Lexington, Kentucky
Owensboro Behavioral Care
Owensboro, Kentucky
Sheppard Pratt Health System
Baltimore, Maryland
Clinical Insights
Glen Burnie, Maryland
Capital Clinical Research Associates
Rockville, Maryland
Psychopharmacology Research Corporation
Farmington Hills, Michigan
University Of Minnesota
Minneapolis, Minnesota
Regions Hospital
Saint Paul, Minnesota
Precise Research Centers
Flowood, Mississippi
University Of Medicine & Dentistry Of New Jersey
Cherry Hill, New Jersey
Buffalo Psychiatric Center
Buffalo, New York
Finger Lakes Clinical Research
Rochester, New York
Richmond Behavioral Associates
Staten Island, New York
Duke University Medical Center
Durham, North Carolina
Zarzar Psychiatric Associates, Pllc
Raleigh, North Carolina
Horizon Medical Services
Bismarck, North Dakota
Neuro Behavioral Clinical Research, Inc.
Canton, Ohio
Community Research
Cincinnati, Ohio
Showing 40 of 66 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.